Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer for p-cresol reduction in CKD
NCT02199444Phase 3Unknown
- Sponsor
- University of Naples Federico II
- Start
- Jun 2014
- Primary completion
- May 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevelamer carbonate in chronic kidney disease (CKD), sponsored by University of Naples Federico II. Status: unknown.
02
Drugs
sevelamer carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02199444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199444.